logo
logo
EXECUTIVE SIGNALS

Real Signals. Real Leads. Real Deals.

The only platform that turns real-time signals into your perfect leads

Know Who, Why, and When to reach out — instantly.

FundzWatch™ AI Scoring
10-25 leads daily
Real-time alerts
★★★★★
4.8/5 on G2• High Performer Fall 2025
Used by teams at LinkedIn, HubSpot & Oracle
🔒 app.fundz.net

DataScale Inc

📍 New York👥 120
85
New Leadership
⭐ Ideal Match

New CRO hired - evaluating tech stack in first 90 days

Covant Therapeutics Appoints Vincent Hennemand As Chief

Oct 13, 2023•almost 2 years ago

Position

Chief Executive Officer

Company

Covant Therapeutics

Vincent Hennemand
Boston

Description

BOSTON, Oct. 13, 2023 -- Covant Therapeutics, an innovative covalent drug discovery company, is pleased to announce the appointment of Vincent Hennemand as Chief Executive Officer .

Company Information

Company

Covant Therapeutics

Location

Boston, Massachusetts, United States

About

Our Mission is to treat diseases with first-and-best-in-class covalent therapeutics for the most significant drug targets by leveraging our cutting-edge capabilities and expertise in chemistry, quantitative proteomics, translational sciences, and deep learning.

Company News

(2 articles)
Fri, 13 Oct 2023 07:00:00 GMT

Covant Therapeutics Appoints Vincent Hennemand as Chief Executive Officer - GlobeNewswire

Tue, 07 Mar 2023 08:00:00 GMT

Covant Therapeutics Announces the Formation of its Scientific Advisory Board to Support Platform and Pipeline Advancement - Yahoo Finance

FundzWatch™ Score

66
Medium Activity

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months